Approval · Notice of Compliance 22183 · 2019
ORILISSA: Notice of Compliance 22183
Issued May 14, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22183
- Date
- May 14, 2019
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- A revision to the drug product specifications
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORILISSA | Not yet assigned | — |
Medicinal ingredients
- ELAGOLIX 200 MG per TAB